Quantitative assessment of autonomic symptom burden in Postural tachycardia syndrome (POTS)
- PMID: 28477704
- DOI: 10.1016/j.jns.2017.03.032
Quantitative assessment of autonomic symptom burden in Postural tachycardia syndrome (POTS)
Abstract
Postural tachycardia syndrome (PoTS) is a poorly understood disorder characterized by excessive tachycardia in the upright position. In addition, patients with PoTS often complain of non-postural symptoms, including fatigue, gastrointestinal and vasomotor fluctuations. The present study quantitatively assessed autonomic symptom burden in PoTS patients (n=32) using the COMPASS-31, compared to that of autonomic failure/neuropathy (AF/N; n=47) and asymptomatic, healthy controls (n=32). Using AIC model selection and regression analysis, we found differences in the contribution of individual COMPASS-31 domains, depending on the autonomic disorder. In PoTS, fatigue severity, orthostatic intolerance and pupillomotor symptom domains, contributed significantly to differences in COMPASS-31 scores compared to controls. In contrast, the secretomotor, gastrointestinal, bladder and vasomotor domains, contributed significantly to the AF/N model. Our results confirm an increase in autonomic symptoms across all functional domains in PoTS compared to controls, and with similar severity to AF/N, though with differing significant domain contributions. Our findings provide additional support that PoTS is indeed a syndrome of autonomic dysfunction beyond orthostatic intolerance, but also indicates the likelihood of disease-specific contributions to symptom burden, highlighting the need for application of expanded physiological assessment beyond orthostatic challenge, as well as disease-specific symptom assessment tools for use in PoTS.
Keywords: Autonomic failure; Autonomic symptoms; Fatigue; Model selection; Postural tachycardia syndrome (PoTS); Pupils.
Copyright © 2017 Elsevier B.V. All rights reserved.
Similar articles
-
Autonomic dysfunction presenting as postural orthostatic tachycardia syndrome in patients with multiple sclerosis.Int J Med Sci. 2010 Mar 11;7(2):62-7. doi: 10.7150/ijms.7.62. Int J Med Sci. 2010. PMID: 20309394 Free PMC article.
-
Gluten-free diet in postural orthostatic tachycardia syndrome (POTS).Chronic Illn. 2023 Jun;19(2):409-417. doi: 10.1177/17423953221076984. Epub 2022 Jan 31. Chronic Illn. 2023. PMID: 35098721
-
Malmö POTS symptom score: Assessing symptom burden in postural orthostatic tachycardia syndrome.J Intern Med. 2023 Jan;293(1):91-99. doi: 10.1111/joim.13566. Epub 2022 Sep 16. J Intern Med. 2023. PMID: 36111700 Free PMC article.
-
Is postural orthostatic tachycardia syndrome (POTS) a central nervous system disorder?J Neurol. 2022 Feb;269(2):725-732. doi: 10.1007/s00415-021-10502-z. Epub 2021 Mar 7. J Neurol. 2022. PMID: 33677650 Free PMC article. Review.
-
Postural Tachycardia Syndrome: Beyond Orthostatic Intolerance.Curr Neurol Neurosci Rep. 2015 Sep;15(9):60. doi: 10.1007/s11910-015-0583-8. Curr Neurol Neurosci Rep. 2015. PMID: 26198889 Free PMC article. Review.
Cited by
-
Fear conditioning as a pathogenic mechanism in the postural tachycardia syndrome.Brain. 2022 Nov 21;145(11):3763-3769. doi: 10.1093/brain/awac249. Brain. 2022. PMID: 35802513 Free PMC article.
-
Noninvasive Vagus Nerve Stimulation in Postural Tachycardia Syndrome: A Randomized Clinical Trial.JACC Clin Electrophysiol. 2024 Feb;10(2):346-355. doi: 10.1016/j.jacep.2023.10.015. Epub 2023 Nov 22. JACC Clin Electrophysiol. 2024. PMID: 37999672 Free PMC article. Clinical Trial.
-
A predictive model of response to metoprolol in children and adolescents with postural tachycardia syndrome.World J Pediatr. 2023 Apr;19(4):390-400. doi: 10.1007/s12519-022-00677-4. Epub 2023 Feb 13. World J Pediatr. 2023. PMID: 36781629 Free PMC article.
-
Postural orthostatic tachycardia syndrome (POTS): Priorities for POTS care and research from a 2019 National Institutes of Health Expert Consensus Meeting - Part 2.Auton Neurosci. 2021 Nov;235:102836. doi: 10.1016/j.autneu.2021.102836. Epub 2021 Jun 30. Auton Neurosci. 2021. PMID: 34246578 Free PMC article.
-
Randomized controlled trial of intravenous immunoglobulin for autoimmune postural orthostatic tachycardia syndrome (iSTAND).Clin Auton Res. 2024 Feb;34(1):153-163. doi: 10.1007/s10286-024-01020-9. Epub 2024 Feb 4. Clin Auton Res. 2024. PMID: 38311655 Clinical Trial.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical